• Hypobetalipoproteinemia
  • VDRL, Serum
  • Nordiazepam, Urine
  • Neisseria gonorrhoeae Nucleic Acid, Liquid Cytology
  • 17-Hydroxyprogesterone, Amniotic fluid
  • The BT-Reveal Early Pancreatic Cancer Test
  • Peripheral Blood Smear Review (Manual Differential)
  • CBFB-MYH11 inv(16) Gene Fusion, Quantitative
  • Cytochrome P450 2C9 (CYP2C9) Genotyping
  • Oxcarbazepine, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /The BT-Reveal Early Pancreatic Cancer Test
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

The BT-Reveal Early Pancreatic Cancer Test
Medical Test

CPT
Access to The BT-Reveal Early Pancreatic Cancer Test is restricted.
Loading...